These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6383521)

  • 61. Retzius cells retain functional membrane properties following 'ablation' by the neurotoxin 5,7-DHT.
    Lent CM; Dickinson MH
    Brain Res; 1984 May; 300(1):167-71. PubMed ID: 6329427
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
    Frankfurt M; Allen DL; Luine VN; Beaudet A
    Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
    Lucot JB; Seiden LS
    Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of and interactions between noradrenergic and serotonergic neurites in the myenteric plexus.
    Gershon MD; Sherman DL
    J Comp Neurol; 1982 Feb; 204(4):407-21. PubMed ID: 6277998
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
    Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
    Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration.
    Gately PF; Segal DS; Geyer MA
    Behav Neural Biol; 1986 Jan; 45(1):31-42. PubMed ID: 3954713
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Compensation in behavioral disorders in rats receiving 5,7-DHT neonatally and by transplantation of embryonic raphe nucleus tissue].
    Semenova TP; Gromov EA; Grishchenko NI; Nesterova IV; Bragin AG; Vinogradova OS; Kulikov AV; Smirnova GN; Tret'iak TM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(1):156-64. PubMed ID: 2162591
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selective demonstration of serotonergic neurons and terminals in electron micrographs: loading with 5,7-dihydroxytryptamine and fixation with NaMnO4.
    Gershon MD; Sherman D
    J Histochem Cytochem; 1982 Aug; 30(8):769-73. PubMed ID: 7119420
    [No Abstract]   [Full Text] [Related]  

  • 69. 5,7-DHT-induced muricide: inhibition as a result of preoperative exposure of rats to mice.
    Marks PC; O'Brien M; Paxinos G
    Brain Res; 1977 Oct; 135(2):383-8. PubMed ID: 562701
    [No Abstract]   [Full Text] [Related]  

  • 70. Ultrastructure of the regenerating growth cones of catecholamine nerve terminals in rat hypothalamic nuclei after 5,7-dihydroxytryptamine administration.
    Chiba T; Murata Y; Shibata H
    Brain Res; 1982 Apr; 238(2):407-12. PubMed ID: 7093661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced spatial discrimination learning in rats following 5,7-DHT-induced serotonergic deafferentation of the hippocampus.
    Altman HJ; Normile HJ; Galloway MP; Ramirez A; Azmitia EC
    Brain Res; 1990 Jun; 518(1-2):61-6. PubMed ID: 1697213
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography.
    Baraban JM; Aghajanian GK
    Brain Res; 1981 Jan; 204(1):1-11. PubMed ID: 6166350
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
    Pranzatelli MR; Snodgrass SR
    Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats.
    Breese GR; Mueller RA
    Ann N Y Acad Sci; 1978 Jun; 305():160-74. PubMed ID: 280248
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion.
    Quattrone A; Schettini G; Annunziato L; Di Renzo G
    Eur J Pharmacol; 1981 Nov; 76(1):9-13. PubMed ID: 7318925
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dihydroxytryptamines as tools to study the neurobiology of serotonin.
    Baumgarten HG; Klemm HP; Sievers J; Schlossberger HG
    Brain Res Bull; 1982; 9(1-6):131-50. PubMed ID: 7172024
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Similarities between aberrant serotonergic fibers in the aged and 5,7-DHT denervated young adult rat brain.
    van Luijtelaar MG; Steinbusch HW; Tonnaer JA
    Exp Brain Res; 1989; 78(1):81-9. PubMed ID: 2591520
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH
    Brain Res; 1989 Dec; 504(2):192-8. PubMed ID: 2598022
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.